Sign in
Back
Cloud-based data systems in drug regulation: an industry perspective
Journal article   Peer reviewed

Cloud-based data systems in drug regulation: an industry perspective

Andrew S. Robertson, Hilary Malone, Fabio Bisordi, Helen Fitton, Carlos Garner, Stacy Holdsworth, Peter Honig, Mathias Hukkelhoven, Robert Kowalski, Sandra Milligan, …
Nature reviews. Drug discovery, Vol.19(6), pp.365-366
2020-06-01
DOI: https://doi.org/10.1038/d41573-019-00193-7
PMID: 32494046

Abstract

Biotechnology & Applied Microbiology Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology
Cloud-based systems for data submitted by sponsors to drug regulatory agencies have the potential to accelerate drug development, streamline regulatory review and enhance regulatory decision-making. Here, we provide a vision for integrating cloud-enabled practices in drug regulation globally.

Metrics

6 Record Views
11 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.155 Medical Ethics
1.155.1510 Orphan Drugs
Web Of Science research areas
Biotechnology & Applied Microbiology
Pharmacology & Pharmacy
ESI research areas
Pharmacology & Toxicology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details